Skip to main content

Advertisement

Log in

Elevated plasma levels of TL1A in newly diagnosed systemic lupus erythematosus patients

  • Short Communication - Food for Thought
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease. Cytokine-mediated immunity plays an important role in the pathogenesis of SLE. TNF-like ligand 1A (TL1A) belongs to the TNF superfamily of cytokines and has been found to perform significantly in autoimmune diseases, such as rheumatoid arthritis and inflammatory bowel disease. To date, no study has discussed the expression levels of TL1A in SLE. We found that plasma levels of TL1A were significantly higher in newly diagnosed SLE patients compared with controls. Correlation analysis showed that plasma levels of TL1A were positively associated with SLE disease activity index. These data indicated that TL1A may play a role in SLE and may reflect the disease activity for SLE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Migone TS, Zhang J, Luo X et al (2002) TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 16(3):479–492

    Article  CAS  PubMed  Google Scholar 

  2. Song L, Zhou R, Huang S et al (2013) High intestinal and systemic levels of interleukin-23/T-helper 17 pathway in Chinese patients with inflammatory bowel disease. Mediat Inflamm 2013:425915

    Article  Google Scholar 

  3. Sun X, Zhao J, Liu R et al (2013) Elevated serum and synovial fluid TNF-like ligand 1A (TL1A) is associated with autoantibody production in patients with rheumatoid arthritis. Scand J Rheumatol 42(2):97–101

    Article  CAS  PubMed  Google Scholar 

  4. Konsta M, Bamias G, Tektonidou MG, Christopoulos P, Iliopoulos A, Sfikakis PP (2013) Increased levels of soluble TNF-like cytokine 1A in ankylosing spondylitis. Rheumatology (Oxford) 52(3):448–451

    Article  CAS  Google Scholar 

  5. Song L, Qiu F, Fan Y et al (2013) Glucocorticoid regulates interleukin-37 in systemic lupus erythematosus. J Clin Immunol 33(1):111–117

    Article  CAS  PubMed  Google Scholar 

  6. Takedatsu H, Michelsen KS, Wei B et al (2008) TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. Gastroenterology 135(2):552–567

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Shih DQ, Zheng L, Zhang X et al (2014) Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis. Mucosal Immunol 7(6):1492–1503

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Wang X, Hu Y, Charpentier T et al (2013) TNF-like ligand 1A (TL1A) gene knockout leads to ameliorated collagen-induced arthritis in mice: implication of TL1A in humoral immune responses. J Immunol 191(11):5420–5429

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was partly supported by Grants from the National Natural Science Foundation of China (81102192, 81172764).

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dong-Qing Ye.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, WD., Chen, DJ., Li, R. et al. Elevated plasma levels of TL1A in newly diagnosed systemic lupus erythematosus patients. Rheumatol Int 35, 1435–1437 (2015). https://doi.org/10.1007/s00296-015-3277-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-015-3277-2

Keywords

Navigation